We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SENATOR STEPS UP SURVEILLANCE OF DRUGMAKERS
SENATOR STEPS UP SURVEILLANCE OF DRUGMAKERS
August 27, 2004
Sen. Chuck Grassley (R-Iowa), the chairman of the Senate Finance Committee, which has partial legislative jurisdiction over the Medicare program, is stepping up his surveillance of drug companies that repeatedly violate corporate integrity agreements they have entered into with the agency.